Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

Conditions:   Esophageal Cancer;   Gastric Cancer
Interventions:   Drug: pembrolizumab;   Drug: trastuzumab;   Drug: capecitabine;   Drug: cisplatin
Sponsor:   Memorial Sloan Kettering Cancer Center
Not yet recruiting - verified November 2016

http://ift.tt/2f5NlZh